Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in…
The bill redirects chronic human-health hazard identification and dose-response assessments formerly performed through EPA’s IRIS program to the EPA program offices responsible for each chemical, provided a program office determines a need. It creates statutory scientific standards, requires program offices to assign toxicity values with ranges and uncertainty, and mandates a chemical assessment database in EPA’s Office of Research and Development.
Centralized IRIS assessments versus decentralizing to program offices
Relative to its intended legislative type, this bill is a primarily administrative/operational measure that is reasonably well-constructed in specifying new roles, a coordinating committee, a database requirement, and scientific standards, but it leaves several practical implementation and resourcing details unspecified.
The bill redirects chronic human-health hazard identification and dose-response assessments formerly performed through EPA’s IRIS program to the EPA program offices responsible for each chemical, provided a program office determines a need.
It creates statutory scientific standards, requires program offices to assign toxicity values with ranges and uncertainty, and mandates a chemical assessment database in EPA’s Office of Research and Development.
The bill establishes a steering committee to coordinate work and avoid duplicate assessments, allows certain third-party assessments, and requires biennial certification to Congressional committees.
Administrative, low-cost changes improve odds, but partisan/regulatory-science stakes and need for cross-committee acceptance reduce likelihood.
Relative to its intended legislative type, this bill is a primarily administrative/operational measure that is reasonably well-constructed in specifying new roles, a coordinating committee, a database requirement, and scientific standards, but it leaves several practical implementation and resourcing details unspecified.
Centralized IRIS assessments versus decentralizing to program offices
These are examples from the analysis, not a ranked list of the most-affected groups.
Centralized IRIS assessments versus decentralizing to program offices
Skeptical.
The persona would be concerned that moving assessments out of IRIS risks fragmenting expertise and politicizing science.
They would note the bill’s statutory scientific standards and peer-review language, but worry implementation and resourcing could weaken consistent protections.
Mixed but cautiously supportive.
The persona would welcome coordination, use-relevance, and clearer standards, while expressing concern about capacity, timelines, and potential duplication without sufficient funding.
Oversight provisions like biennial certification are viewed as useful checks.
Generally supportive.
The persona would favor decentralizing assessments to program offices and using use-relevant science, arguing this reduces central bureaucracy and aligns science with regulatory contexts.
They may object to added reporting burdens but appreciate third-party inclusion and transparency requirements.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Administrative, low-cost changes improve odds, but partisan/regulatory-science stakes and need for cross-committee acceptance reduce likelihood.
The bill has not accumulated any surfaced votes yet.
Centralized IRIS assessments versus decentralizing to program offices
Administrative, low-cost changes improve odds, but partisan/regulatory-science stakes and need for cross-committee acceptance reduce likeli…
Relative to its intended legislative type, this bill is a primarily administrative/operational measure that is reasonably well-constructed in specifying new roles, a coordinating committee, a database requirement, and s…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.